Inhaled Nitric Oxide and Pulmonary Vasoreactivity

被引：0
|
作者：
Margaret Aranda
Ronald G. Pearl
机构：
[1] University of Pennsylvania,Department of Anesthesia
[2] Stanford University School of Medicine,Department of Anesthesia
来源：
Journal of Clinical Monitoring and Computing | 2000年 / 16卷
关键词：
Inhaled nitric oxide; pulmonary hypertension; adult respiratory distress syndrome; “rebound” phenomenon; persistent pulmonary hypertension of the newborn; cardiac surgery; thoracic surgery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Inhaled nitric oxide is a ubiquitous molecule which is produced endogenously and is also found in air pollution and in cigarette smoke. After describing the chemistry of NO, we review its history from the first description in 1980 to the current clinical indications. The biosynthesis of NO, its effects on pulmonary vasoreactivity, and the administration of inhaled NO will be described. The indications, uses, and side effects of inhaled NO are discussed with an emphasis on withdrawal of NO therapy, specifically the “rebound” phenomenon. Possible drug interactions are listed. Inhaled nitric oxide is here to stay, and future studies will provide more information on its therapeutic dose, duration and potential toxicity.
引用
收藏
页码：393 / 401
页数：8
相关论文
共 50 条
  • [11] Vasoreactivity with inhaled nitric oxide and 100% oxygen in patient's with idiopathic pulmonary fibrosis and pulmonary arterial hypertension
    Anand, Wayneinder S.
    Shapiro, Shelley
    Saggar, Rajeev
    Saggar, Rajan
    Belperio, John A.
    Lynch, Joseph P., III
    Zisman, David A.
    CHEST, 2007, 132 (04) : 583S - 583S
  • [12] What definition of vasoreactivity to inhaled nitric oxide best predicts mortality risk in patients with pulmonary hypertension?
    Krasuski, RA
    Smith, B
    Wang, A
    Harrison, JK
    Johnson, M
    Pierce, C
    Tapson, VF
    Bashore, TM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 411A - 411A
  • [13] Inhaled nitric oxide and pulmonary embolism
    J. E. Tanus-Santos
    G. Capellier
    T. Jacques
    P. Balvay
    F. Barale
    Intensive Care Medicine, 1998, 24 (7) : 747 - 748
  • [14] Inhaled nitric oxide and pulmonary embolism
    Tanus-Santos, JE
    INTENSIVE CARE MEDICINE, 1998, 24 (07) : 747 - 747
  • [15] Vasoreactivity in Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension - A Case of Robust Response to Inhaled Nitric Oxide (iNO)
    Seth, R.
    Atchley, W. T.
    Brewer, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [16] Inhaled nitric oxide in postpneumonectomy pulmonary edema
    MT Keegan
    ML De Ruyter
    C Deschamps
    BA Harrison
    Critical Care, 7 (Suppl 2):
  • [17] Inhaled nitric oxide in patients with pulmonary embolism
    J. E. Tulleken
    T. S. van der Werf
    J. E. Tulleken
    G. Capellier
    T. Jacques
    P. Balvay
    F. Barale
    Intensive Care Medicine, 1998, 24 (4) : 399 - 400
  • [18] Inhaled Nitric Oxide in Neonatal Pulmonary Hypertension
    Cookson, Michael W.
    Kinsella, John P.
    CLINICS IN PERINATOLOGY, 2024, 51 (01) : 95 - 111
  • [19] Inhaled nitric oxide as an adjunct to pulmonary thromboendarterectomy
    Pinelli, G
    Mertes, PM
    Carteaux, JP
    Hubert, T
    Dopff, C
    Burtin, P
    Villemot, JP
    ANNALS OF THORACIC SURGERY, 1996, 61 (01): : 227 - 229
  • [20] Inhaled nitric oxide and pulmonary edema formation
    Booke, M
    VanAken, H
    Waurick, R
    Hinder, F
    Meyer, J
    Traber, DL
    CRITICAL CARE MEDICINE, 1997, 25 (12) : 2066 - 2066
12345